Skip to main content

GSA CAPITAL PARTNERS LLP

Position in IMVT — Immunovant, Inc.

CIK 1362033 LONDON, X0

Position in IMVT

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,514,737
+$705,889 QoQ
Shares Held
65,267
-10.4% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#79
of 223 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. IMVT ranks #2 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 IMVT
Immunovant, Inc.
This page
65,267 $2,514,737

All Filings in IMVT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,514,737 65,267
2026-03-31 $1,808,848 72,820
2025-12-31 $1,122,038 44,140
2025-09-30 $437,625 27,148
2024-09-30 $702,315 24,634
2024-06-30 $391,353 14,824
2023-12-31 $369,058 8,760
2023-06-30 $621,001 32,736
2022-09-30 $530,914 95,146
2022-06-30 $155,286 39,817
2021-12-31 $346,372 40,654
2021-09-30 $705,367 81,170
2020-12-31 $239,033 5,175